the aid library

LIST OPTIONS

Filter

7075

Руководствопо эпиднадзоруза ВИЧ-инфекцией у больных туберкулезом (Guidelines for HIV surveillance among tuberculosis patients, 2nd ed Russian Version)

Erika Duffell, Igor Toskin World Health Organization (2007) C_WHO

Основная цель этого Руководства состоит в том, чтобы очертить рамки методов, используемых для оценки распространенности ВИЧ-инфекции среди больных туберкулезом и... more

External Link

Alternative Thematic Report on implementation of the Convention on Elimination of all Forms of discrimination against Women on the issues related to women living with HIV from the affected groups

Republic of Tajikistan; Tajikistan Network of Women living with HIV (Public Organization) (2019) C2

Alternative Thematic Report on implementation of the Convention on Elimination of all Forms of discrimination against Women on the issues related to women living with HIV from the affected groups (women – former prisoners, women using injected drugs, women sex workers). Accessed: 04.10.2019

Download (132)

View PDF (157)

Policy Brief to Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy

World Health Organization (2017) C_WHO

HIV treatment Policy brief July 2017 WHO/HIV/2017.18

Download (124)

View PDF (153)

Field Guide for Implementation of the Strategy and Plan of Action for Elimination of Mother-to-Child Transmission of HIV and Congenital Syphilis in the Americas

Pan American Health Organization; World Health Organization (Americas) (2014) C_WHO

Download (115)

View PDF (153)

Tackling HIV Drug Resistance: Trends, guidelines and global action

World Health Organization WHO (2017) C_WHO

Assessment of the Implementation of the Regional Health Sector Strategy on HIV

World Health Organization (Regional Office for South-East-Asia) World Health Organization (Regional Office for South-East-Asia) (2016) C_WHO

2011-2015

Download (258)

View PDF (196)

South African National Guidelines for Medical Male Circumcision

National Department of Health (Republic of South Africa) National Department of Health (Republic of South Africa) (2020) C2

Accessed: 03.03.2020

External Link

Analysis of the challenges in implementing guidelines to prevent the spread of multidrug-resistant gram-negativs in Europe

Evelina Tacconelli, Michael Buhl, Hilary Humphreys et al. (2019) C2

The global increase of healthcare-associated infections (HAI) presents a growing concern in healthcare worldwide. According to the European Centre for Disease Prevention and Control (ECDC), the annual number of HAI exceeds 2.6million and produces the highest estimated amou... more

Polio eradication programme continuity: implementation in the context of the COVID-19 pandemic

Polio Global Eradication Initiative (2020) C_WHO

- Interim guide: May 2020 update. On the 25th of March, the GPEI circulated the first update of the interim guide to help ensure continuity of the programme’s operations in the context of the COVID-19 pandemic, as well as its support to the pandemic response while also ensuring the safety of its ... more

Download (166)

View PDF (171)

Promoting Positive Environments for Women and Girls - Guidelines for Women and Girls Friendly Spaces in South Sudan

UNICEF (2015) C_UNICEF

The creaNon of ‘friendly spaces’ for women and girls has been a key strategy in the protecNon and empowerment of women 1 and girls in South Sudan since conflict re-erupted in the country in December 2013. This document provides guidance on the aims of these spaces, and how they can best be e... more

COVID-19 Disease: Infection Prevention and Control Guidelines (South Africa)

Ministry of Health, South Africa (2020) CC

April 2020

Download (153)

View PDF (131)

Integrated Management of Acute Malnutrition National Guidelines

Islamic Republic of Afghanistan Ministry of Public Health General Directorate of Preventive Medicine Public Nutrition Directorate (2018) C1

Integrated Management of Acute Malnutrition National Guidelines

Communicating about Vaccine Safety: Guidelines to help health workers communicate with parents, caregivers, and patients

Pan American Health Organisation PAHO (2020) C_WHO

28 Dec 2020. The main objective of these guidelines is to provide tools for staff working in the field of immunization to support effective communication between health personnel and the general population, with the aim of strengthening, maintaining or recovering trust in vaccines and the immunizati... more

External Link

European Resuscitation Council Guidelines 2021: Paediatric Life Support

Van de Voorde, P.; et al. European Resuscitation Council (2021) CC

Download (159)

View PDF (170)

Hearing screening: considerations for implementation

World Health Organization WHO (2021) C_WHO

African Antibiotic Treatment Guidelines for Common Bacterial Infections and Syndromes – Final Report

Africa Centres for Disease Control and Prevention Center for Disease Dynamics, Economics & Policy Africa Centres for Disease Control and Prevention Center for Disease Dynamics, Economics & Policy (2021) CC

Download (125)

View PDF (156)

COVID-19 infection prevention and control living guideline: mask use in community settings, 22 December 2021

World Health Organization WHO (2021) C_WHO

22 December 2021

Download (223)

View PDF (216)

Caregiver skills training for families of children with developmental delays or disabilities - Adaptation and implementation guide

World Health Organization WHO (2022) C_WHO

This adaptation and implementation guide is part of a five-part Caregiver skills training for families of children with developmental delays or disabilities (CST) package providing guidance on caregiver skills training for families of children aged 2–9 years with developmental delays or disabiliti... more

Download (285)

View PDF (384)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (200)

View PDF (202)

Guidance on development and implementation of a national deployment and vaccination plan for vaccines against pandemic influenza and other respiratory viruses of pandemic potential

World Health Organization WHO (2023) C_WHO

Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a... more